VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

live attenuated Brucella abortus betB deletion mutant vaccine
Vaccine Information
  • Vaccine Name: live attenuated Brucella abortus betB deletion mutant vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009289
  • Type: Live attenuated vaccine
  • Status: Research
  • Host Species for Licensed Use: Cattle
  • Host Species as Laboratory Animal Model: HeLa cells; RAW 264.7 macrophages; Mus musculus
  • Antigen: betB deletion mutant
  • Preparation: Live betB deletion mutant strain of Brucella abortus. (Lee et al, 2014)
  • Description: The study investigated a betB deletion mutant constructed from virulent Brucella abortus 544 as a potential vaccine candidate. Efficacy: The betB mutant was predominantly cleared from mouse spleens after 2 weeks post-infection and vaccination with the live betB mutant provided effective protection against challenge with the virulent wild-type strain. Immune response: The betB mutant showed increased adherence to host cells and enhanced phosphorylation of protein kinases promoting phagocytic activity; intracellular trafficking showed elevated colocalization with LAMP-1, indicating altered phagocytic pathway engagement. (Lee et al, 2014)
Host Response

Mouse Response

  • Immune Response: The betB mutant showed increased adherence to host cells and enhanced phosphorylation of protein kinases promoting phagocytic activity; intracellular trafficking showed elevated colocalization with LAMP-1, indicating altered phagocytic pathway engagement. (Lee et al, 2014)
  • Challenge Protocol: In vitro stress resistance tests (osmotic and acid stress), internalization and replication assays in HeLa cells and RAW 264.7 macrophages, intracellular trafficking analysis with LAMP-1 colocalization, and in vivo mouse infection and vaccination challenge experiments. (Lee et al, 2014)
  • Efficacy: The betB mutant was predominantly cleared from mouse spleens after 2 weeks post-infection and vaccination with the live betB mutant provided effective protection against challenge with the virulent wild-type strain. (Lee et al, 2014)
  • Description: In vitro stress resistance tests (osmotic and acid stress), internalization and replication assays in HeLa cells and RAW 264.7 macrophages, intracellular trafficking analysis with LAMP-1 colocalization, and in vivo mouse infection and vaccination challenge experiments. (Lee et al, 2014)
References
Lee et al, 2014: Lee JJ, Kim JH, Kim DG, Kim DH, Simborio HL, Min WG, Rhee MH, Lim JH, Chang HH, Kim S. Characterization of betaine aldehyde dehydrogenase (BetB) as an essential virulence factor of Brucella abortus. Veterinary microbiology. 2014 Jan 10; 168(1); 131-40. [PubMed: 24210811].